Pediatric oncology: past, present, and new modalities of treatment.
Although the past two decades have shown a remarkable improvement in the survival rate of children with malignant disorders, cancer is still the primary cause of death from disease in children who are between 1 and 14 years old. This article gives an overview of past, current, and future direction of pediatric cancer treatment modalities.
Bertolone
K
K
Alliant Health System, Inc., Louisville, Kentucky, USA.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002648:Child; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008495:Medical Oncology / Q000639:trends*; D009369:Neoplasms / Q000628:therapy*; D010372:Pediatrics / Q000639:trends*
D000970:Antineoplastic Agents